SCIENTIFIC PROGRAMME

2.00pm - 2.30pm

CLINICAL

EARLY CAREER DEVELOPMENT

LABORATORY

NURSING AND PHARMACY

7.00 - 8.00 am

Registration

EDUCATION SESSION 1

Acute Myeloid Leukaemia

Decoding AML: Bridging Genomics and Clinical Practice

TBC

TBC

TBC

8.00 - 8.25 am

Targeting the Genome: Precision Medicine Approaches in AML

TBC

Bone Marrow Trephine Biopsy Assessment After Chemotherapy

TBC

8.25 - 8.50 am

From ‘7+3’ to Smart Drugs: The Therapeutic Revolution in AML

TBC

Granuloma in Bone Marrow

Overview of Haematological Malignancies: A Nursing Perspective

8.50 - 9.15 am

Minimal Residual Disease and AML Transplantation: The MRD-Guided Era

TBC

TBC

Safe Chemotherapy Management: Defining Nursing and Pharmacy Roles from Verification to Delivery

9.15 - 9.30 am

Panel Discussion

TBC

Panel Discussion

Panel Discussion

9.30 - 9.45 am

Industry Showcase / Poster walk

10.00 - 10.30 am

Opening Ceremony

10.30 - 11.15 am

Plenary Lecture

EDUCATION SESSION 2

Lymphoma

Modern Management of Hodgkin Lymphoma: Balancing Cure, Toxicity, and Quality of Life

Haemostasis and Thrombosis

From Bleeding to Clotting: Clinical Challenges in Haemostasis and Thrombosis

TBC

TBC

11.15 - 11.40 am

Epidemiology of Hodgkin Lymphoma: Global Patterns, Local Realities

How I Treat Bleeding Disorders: From Laboratory Evaluation to Bedside Management

Current Practice of BCP-ALL MRD in Flow Cytometry and Next Generation Flow

Weight-Adjusted Chemotherapy Dosing in Haematology: Is Ideal Body Weight the Preferred Metric?

11.40 - 12.05 pm

Optimising Frontline Therapy in Hodgkin Lymphoma: Balancing Efficacy and Late Effects

How I Treat Venous Thromboembolism: The Nuances of Clinical Management

BCP-ALL MRD: Case Studies Discussion

Nursing Challenges in Chemotherapy Administration for Haematology Patients

12.05 - 12.30 pm

Managing Relapsed Hodgkin Lymphoma: Integrating Transplantation and Immunotherapy

How I Treat Thrombocytopenia: From First Platelet Count to Targeted Therapy

TBC

Symptom Control and Goal-Concordant Care for Critically Ill Patients with Relapsed or Refractory Haematologic Malignancies

12.30 - 12.45 pm

Panel Discussion

Panel Discussion

Panel Discussion

Panel Discussion

12.45 - 1.45 pm

Lunch Symposium 1 (Exclusive to Platinum Sponsors)

1.45 - 2.30 pm

Friday Prayers

EDUCATION SESSION 3

Plasma Cell Disorders

Myeloma: Is a Cure on the Horizon?

Oral Presentations

TBC

TBC

2.30 - 2.55 pm

2.55 - 3.20 pm

3.20 - 3.30 pm

Triplets, Quadruplets, and Beyond: Optimising Frontline Myeloma Therapy

Toward Functional Cure: Emerging Therapies in Relapsed and Refractory Myeloma

Panel Discussion

Clinical and Laboratory

When Genes Collide: Co-Inheritance of SAO and Thalassemia—Does It Really Matter?

TBC

Panel Discussion

Optimising Patient Readiness for Haematopoietic Stem Cell Transplantation: A Nursing Perspective

TBC

Panel Discussion

3.30 - 3.45 pm

Industry Showcase / Poster Walk

3.45 - 4.30 pm

Tea Break Symposium 1 (Exclusive to Gold Sponsors)

Tea Break Symposium 2 (Exclusive to Gold Sponsors)

4.30 - 5.30 pm

Advancing Clinical Haematology in Malaysia: Best Practices and Innovations

6.30 - 9.30 pm

Faculty Dinner (By Invitation Only)

2.00pm - 2.30pm

CLINICAL

EARLY CAREER DEVELOPMENT

LABORATORY

NURSING AND PHARMACY

7.30 - 8.30 am

Registration

Expert Roundtable (By Invitation Only)

EDUCATION SESSION 4

Acute Lymphoblastic Leukaemia

How to treat AYA ALL?

Comprehensive Haemato-Oncology Care

Navigating Complications Across the Chemo–Transplant Continuum

TBC

TBC

8.30 - 8.55 am

AYA Acute Lymphoblastic Leukemia:
Bridging Pediatric and Adult Protocols

How I manage post-transplant patients: Monitoring, Complications, and Long-Term Care

Pathology in Malaysia: Current Challenges, Future Directions, and Strategic Development

Best Nursing Practices in CLABSI Prevention in Haematology Units

8.55 - 9.20 am

AYA ALL: Is Transplant Still the Gold Standard?

How I Support Patients After Chemotherapy Toxicity Management, Monitoring, and Survivorship Care

BCR::ABL1 Monitoring in Chronic Myeloid Leukaemia

TBC

9.20 - 09.45 am

High-Risk AYA ALL: Contemporary Challenges and Evolving Solutions

How I Treat Infections in Haematology Patients: Practical Strategies for Clinicians

TBC

TBC

9.45 - 10.00 am

Panel Discussion

Panel Discussion

Panel Discussion

Panel Discussion

10.00 - 10.45 am

Tea Break Symposium 3 (Exclusive to Gold Sponsors)

Tea Break Symposium 4 (Exclusive to Gold Sponsors)

EDUCATION SESSION 5

Indolent Lymphoma

Current Practice and Future Directions

Oral Presentations

TBC

TBC

10.45 - 11.10 am

11.10 - 11.35 am

11.35 - 12.00 pm

12.00 - 12.15 pm

Marginal Zone Lymphoma: Understanding the Biology of MZL: From Splenic to Extranodal Subtypes

Advancements in Treatment of R/R FL

Optimizing Treatment Strategies in Hairy Cell Leukemia: From Purine Analogues to Immunotherapy

Panel Discussion

Clinical and Laboratory

CD20 Negative Lymphomas: Diagnostic Pitfalls and Practical Approach in Trephine Biopsy

T-Cell Lymphomas: A Practical Morphology– Immunophenotype Approach in Trephine Biopsy

TBC

Panel Discussion

Central Venous Access Device (CVAD) Care: PICC Lines and Chemoports

Practical Skills Masterclass:
Station 1: PICC line care
Station 2: Chemoport care

Panel Discussion

12.15 - 1.00 pm

Dr John Bosco Lecture

1.00 - 2.00 pm

Lunch Symposium 2 (Exclusive to Platinum Sponsors)

EDUCATION SESSION 6

Marrow Failure Syndromes

Anaemia

Practical Management in Adults

TBC

TBC

2.00 - 2.25 pm

Acquired Aplastic Anemia Frontline Treatment Optimization: IST + Eltrombopag and Beyond

How I Treat Haemolytic Anaemia: A Practical, Case-Based Approach

Red Cell Alloantibodies in Pregnancy: Clinical Challenges and Management

Unmet Needs in Malaysian Haemophilia Care: Transition from Paediatric to Adult Services

2.25 - 2.50 pm

Advances in Haploidentical HSCT for Aplastic Anaemia

How I Treat Iron Deficiency Anaemia: To Transfuse or Not Transfuse?

Management of the Multiply Alloimmunised Patient: From Transfusion Strategy to Clinical Intervention

TBC

2.50 - 3.15 pm

Unmasking Hidden Hereditary Marrow Failure: Clinical Clues Across the Age Spectrum

How I Manage Thalassemia: Comprehensive Management and Future Directions

TBC

TBC

3.15 - 3.30 pm

Panel Discussion

Panel Discussion

Panel Discussion

Panel Discussion

3.30 - 3.45 pm

Industry Showcase / Poster Walk

3.45 - 4.30 pm

Tea Break Symposium 5 (Exclusive to Gold Sponsors)

Tea Break Symposium 6 (Exclusive to Gold Sponsors)

4.30 - 5.00 pm

Prize Giving and Closing Ceremony